Analyzing Prognostic and Immune Characteristics of Kidney Renal Clear Cell Carcinoma through Mitochondria-Associated Membranes and Identifying DNM1L as a Potential Target for Therapy Using Machine Learning Techniques - Top-Institutions - MDSpire

Analyzing Prognostic and Immune Characteristics of Kidney Renal Clear Cell Carcinoma through Mitochondria-Associated Membranes and Identifying DNM1L as a Potential Target for Therapy Using Machine Learning Techniques

  • By

  • Sheng Li

  • Jinkang Lin

  • Fucun Zheng

  • Xiaoqiang Liu

  • Situ Xiong

  • Bin Fu

  • Jin Zeng

  • January 22, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Oncology
    • Urologic Oncology
    • Cancer Immunotherapy
    • Computational Biology

  • #2

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Medical Oncology
    • Cancer Genomics
    • Immunotherapy
    • Bioinformatics

  • #3

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Oncology
    • Translational Cancer Research
    • Immuno-oncology
    • Systems Biology

  • #4

    Johns Hopkins University School of Medicine
    Johns Hopkins University School of Medicine

    Baltimore, MD

    Key Differentiators

    • Urologic Oncology
    • Cancer Biology
    • Computational Medicine

  • #5

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Oncology
    • Cancer Genomics
    • Immunotherapy
    • Computational Oncology

Original Source(s)

Analyzing Prognostic and Immune Characteristics of Kidney Renal Clear Cell Carcinoma through Mitochondria-Associated Membranes and Identifying DNM1L as a Potential Target for Therapy Using Machine Learning Techniques

  • by Sheng Li, Jinkang Lin, Fucun Zheng, Xiaoqiang Liu, Situ Xiong, Bin Fu, Jin Zeng

  • January 22, 2026

Related Content

The role of NAD+ metabolic reprogramming in colorectal cancer chemoresistance: mechanistic insights, clinical translation challenges and opportunities

Data requirements of an informative, directive, and preventive mobile health application for gastric cancer

Ultra-high-sensitivity next-generation sequencing–based MRD predicts outcome in intensively treated older patients with acute myeloid leukemia: results from the ALFA-1200 cohort